Already positive, the research from JP Morgan and its analyst Douglas Anmuth still consider the stock as a Buy opportunity. The target price is unchanged and still at USD 650.
Already positive, the research from JP Morgan and its analyst Douglas Anmuth still consider the stock as a Buy opportunity. The target price is increased from USD 610 to USD 650.